Global VLP Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
VLP vaccines are a type of recombinant vaccine, but they offer the efficiency of a live-attenuated vaccine. Recombinant vaccines use a particular piece of the germ that the immune system targets specifically.
LPI (LP Information)' newest research report, the “VLP Vaccines Industry Forecast” looks at past sales and reviews total world VLP Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected VLP Vaccines sales for 2023 through 2029. With VLP Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world VLP Vaccines industry.
This Insight Report provides a comprehensive analysis of the global VLP Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on VLP Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global VLP Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for VLP Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global VLP Vaccines.
The global VLP Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for VLP Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for VLP Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for VLP Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key VLP Vaccines players cover Medicago, Novavax, Saiba Animal Health, VBI, ARTES Biotechnology, VLP Therapeutics, POSVAX, Spybiotech and Optipharm Co. Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of VLP Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global VLP Vaccines market?
What factors are driving VLP Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do VLP Vaccines market opportunities vary by end market size?
How does VLP Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
VLP vaccines are a type of recombinant vaccine, but they offer the efficiency of a live-attenuated vaccine. Recombinant vaccines use a particular piece of the germ that the immune system targets specifically.
LPI (LP Information)' newest research report, the “VLP Vaccines Industry Forecast” looks at past sales and reviews total world VLP Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected VLP Vaccines sales for 2023 through 2029. With VLP Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world VLP Vaccines industry.
This Insight Report provides a comprehensive analysis of the global VLP Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on VLP Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global VLP Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for VLP Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global VLP Vaccines.
The global VLP Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for VLP Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for VLP Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for VLP Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key VLP Vaccines players cover Medicago, Novavax, Saiba Animal Health, VBI, ARTES Biotechnology, VLP Therapeutics, POSVAX, Spybiotech and Optipharm Co. Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of VLP Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- HPV Vaccine
- Covid-19 Vaccine
- Hepatitis B Vaccine
- Others
- Government
- Medical Institution
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medicago
- Novavax
- Saiba Animal Health
- VBI
- ARTES Biotechnology
- VLP Therapeutics
- POSVAX
- Spybiotech
- Optipharm Co. Ltd
- H&Z Life Science
- Gproan
- Merck
What is the 10-year outlook for the global VLP Vaccines market?
What factors are driving VLP Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do VLP Vaccines market opportunities vary by end market size?
How does VLP Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global VLP Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for VLP Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for VLP Vaccines by Country/Region, 2018, 2022 & 2029
2.2 VLP Vaccines Segment by Type
2.2.1 HPV Vaccine
2.2.2 Covid-19 Vaccine
2.2.3 Hepatitis B Vaccine
2.2.4 Others
2.3 VLP Vaccines Sales by Type
2.3.1 Global VLP Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global VLP Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global VLP Vaccines Sale Price by Type (2018-2023)
2.4 VLP Vaccines Segment by Application
2.4.1 Government
2.4.2 Medical Institution
2.4.3 Others
2.5 VLP Vaccines Sales by Application
2.5.1 Global VLP Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global VLP Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global VLP Vaccines Sale Price by Application (2018-2023)
3 GLOBAL VLP VACCINES BY COMPANY
3.1 Global VLP Vaccines Breakdown Data by Company
3.1.1 Global VLP Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global VLP Vaccines Sales Market Share by Company (2018-2023)
3.2 Global VLP Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global VLP Vaccines Revenue by Company (2018-2023)
3.2.2 Global VLP Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global VLP Vaccines Sale Price by Company
3.4 Key Manufacturers VLP Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers VLP Vaccines Product Location Distribution
3.4.2 Players VLP Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VLP VACCINES BY GEOGRAPHIC REGION
4.1 World Historic VLP Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global VLP Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global VLP Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic VLP Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global VLP Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global VLP Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas VLP Vaccines Sales Growth
4.4 APAC VLP Vaccines Sales Growth
4.5 Europe VLP Vaccines Sales Growth
4.6 Middle East & Africa VLP Vaccines Sales Growth
5 AMERICAS
5.1 Americas VLP Vaccines Sales by Country
5.1.1 Americas VLP Vaccines Sales by Country (2018-2023)
5.1.2 Americas VLP Vaccines Revenue by Country (2018-2023)
5.2 Americas VLP Vaccines Sales by Type
5.3 Americas VLP Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC VLP Vaccines Sales by Region
6.1.1 APAC VLP Vaccines Sales by Region (2018-2023)
6.1.2 APAC VLP Vaccines Revenue by Region (2018-2023)
6.2 APAC VLP Vaccines Sales by Type
6.3 APAC VLP Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe VLP Vaccines by Country
7.1.1 Europe VLP Vaccines Sales by Country (2018-2023)
7.1.2 Europe VLP Vaccines Revenue by Country (2018-2023)
7.2 Europe VLP Vaccines Sales by Type
7.3 Europe VLP Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa VLP Vaccines by Country
8.1.1 Middle East & Africa VLP Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa VLP Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa VLP Vaccines Sales by Type
8.3 Middle East & Africa VLP Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of VLP Vaccines
10.3 Manufacturing Process Analysis of VLP Vaccines
10.4 Industry Chain Structure of VLP Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 VLP Vaccines Distributors
11.3 VLP Vaccines Customer
12 WORLD FORECAST REVIEW FOR VLP VACCINES BY GEOGRAPHIC REGION
12.1 Global VLP Vaccines Market Size Forecast by Region
12.1.1 Global VLP Vaccines Forecast by Region (2024-2029)
12.1.2 Global VLP Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global VLP Vaccines Forecast by Type
12.7 Global VLP Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medicago
13.1.1 Medicago Company Information
13.1.2 Medicago VLP Vaccines Product Portfolios and Specifications
13.1.3 Medicago VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medicago Main Business Overview
13.1.5 Medicago Latest Developments
13.2 Novavax
13.2.1 Novavax Company Information
13.2.2 Novavax VLP Vaccines Product Portfolios and Specifications
13.2.3 Novavax VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novavax Main Business Overview
13.2.5 Novavax Latest Developments
13.3 Saiba Animal Health
13.3.1 Saiba Animal Health Company Information
13.3.2 Saiba Animal Health VLP Vaccines Product Portfolios and Specifications
13.3.3 Saiba Animal Health VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Saiba Animal Health Main Business Overview
13.3.5 Saiba Animal Health Latest Developments
13.4 VBI
13.4.1 VBI Company Information
13.4.2 VBI VLP Vaccines Product Portfolios and Specifications
13.4.3 VBI VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 VBI Main Business Overview
13.4.5 VBI Latest Developments
13.5 ARTES Biotechnology
13.5.1 ARTES Biotechnology Company Information
13.5.2 ARTES Biotechnology VLP Vaccines Product Portfolios and Specifications
13.5.3 ARTES Biotechnology VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 ARTES Biotechnology Main Business Overview
13.5.5 ARTES Biotechnology Latest Developments
13.6 VLP Therapeutics
13.6.1 VLP Therapeutics Company Information
13.6.2 VLP Therapeutics VLP Vaccines Product Portfolios and Specifications
13.6.3 VLP Therapeutics VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 VLP Therapeutics Main Business Overview
13.6.5 VLP Therapeutics Latest Developments
13.7 POSVAX
13.7.1 POSVAX Company Information
13.7.2 POSVAX VLP Vaccines Product Portfolios and Specifications
13.7.3 POSVAX VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 POSVAX Main Business Overview
13.7.5 POSVAX Latest Developments
13.8 Spybiotech
13.8.1 Spybiotech Company Information
13.8.2 Spybiotech VLP Vaccines Product Portfolios and Specifications
13.8.3 Spybiotech VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Spybiotech Main Business Overview
13.8.5 Spybiotech Latest Developments
13.9 Optipharm Co. Ltd
13.9.1 Optipharm Co. Ltd Company Information
13.9.2 Optipharm Co. Ltd VLP Vaccines Product Portfolios and Specifications
13.9.3 Optipharm Co. Ltd VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Optipharm Co. Ltd Main Business Overview
13.9.5 Optipharm Co. Ltd Latest Developments
13.10 H&Z Life Science
13.10.1 H&Z Life Science Company Information
13.10.2 H&Z Life Science VLP Vaccines Product Portfolios and Specifications
13.10.3 H&Z Life Science VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 H&Z Life Science Main Business Overview
13.10.5 H&Z Life Science Latest Developments
13.11 Gproan
13.11.1 Gproan Company Information
13.11.2 Gproan VLP Vaccines Product Portfolios and Specifications
13.11.3 Gproan VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Gproan Main Business Overview
13.11.5 Gproan Latest Developments
13.12 Merck
13.12.1 Merck Company Information
13.12.2 Merck VLP Vaccines Product Portfolios and Specifications
13.12.3 Merck VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Merck Main Business Overview
13.12.5 Merck Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global VLP Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for VLP Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for VLP Vaccines by Country/Region, 2018, 2022 & 2029
2.2 VLP Vaccines Segment by Type
2.2.1 HPV Vaccine
2.2.2 Covid-19 Vaccine
2.2.3 Hepatitis B Vaccine
2.2.4 Others
2.3 VLP Vaccines Sales by Type
2.3.1 Global VLP Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global VLP Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global VLP Vaccines Sale Price by Type (2018-2023)
2.4 VLP Vaccines Segment by Application
2.4.1 Government
2.4.2 Medical Institution
2.4.3 Others
2.5 VLP Vaccines Sales by Application
2.5.1 Global VLP Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global VLP Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global VLP Vaccines Sale Price by Application (2018-2023)
3 GLOBAL VLP VACCINES BY COMPANY
3.1 Global VLP Vaccines Breakdown Data by Company
3.1.1 Global VLP Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global VLP Vaccines Sales Market Share by Company (2018-2023)
3.2 Global VLP Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global VLP Vaccines Revenue by Company (2018-2023)
3.2.2 Global VLP Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global VLP Vaccines Sale Price by Company
3.4 Key Manufacturers VLP Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers VLP Vaccines Product Location Distribution
3.4.2 Players VLP Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VLP VACCINES BY GEOGRAPHIC REGION
4.1 World Historic VLP Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global VLP Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global VLP Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic VLP Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global VLP Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global VLP Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas VLP Vaccines Sales Growth
4.4 APAC VLP Vaccines Sales Growth
4.5 Europe VLP Vaccines Sales Growth
4.6 Middle East & Africa VLP Vaccines Sales Growth
5 AMERICAS
5.1 Americas VLP Vaccines Sales by Country
5.1.1 Americas VLP Vaccines Sales by Country (2018-2023)
5.1.2 Americas VLP Vaccines Revenue by Country (2018-2023)
5.2 Americas VLP Vaccines Sales by Type
5.3 Americas VLP Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC VLP Vaccines Sales by Region
6.1.1 APAC VLP Vaccines Sales by Region (2018-2023)
6.1.2 APAC VLP Vaccines Revenue by Region (2018-2023)
6.2 APAC VLP Vaccines Sales by Type
6.3 APAC VLP Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe VLP Vaccines by Country
7.1.1 Europe VLP Vaccines Sales by Country (2018-2023)
7.1.2 Europe VLP Vaccines Revenue by Country (2018-2023)
7.2 Europe VLP Vaccines Sales by Type
7.3 Europe VLP Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa VLP Vaccines by Country
8.1.1 Middle East & Africa VLP Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa VLP Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa VLP Vaccines Sales by Type
8.3 Middle East & Africa VLP Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of VLP Vaccines
10.3 Manufacturing Process Analysis of VLP Vaccines
10.4 Industry Chain Structure of VLP Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 VLP Vaccines Distributors
11.3 VLP Vaccines Customer
12 WORLD FORECAST REVIEW FOR VLP VACCINES BY GEOGRAPHIC REGION
12.1 Global VLP Vaccines Market Size Forecast by Region
12.1.1 Global VLP Vaccines Forecast by Region (2024-2029)
12.1.2 Global VLP Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global VLP Vaccines Forecast by Type
12.7 Global VLP Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medicago
13.1.1 Medicago Company Information
13.1.2 Medicago VLP Vaccines Product Portfolios and Specifications
13.1.3 Medicago VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medicago Main Business Overview
13.1.5 Medicago Latest Developments
13.2 Novavax
13.2.1 Novavax Company Information
13.2.2 Novavax VLP Vaccines Product Portfolios and Specifications
13.2.3 Novavax VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novavax Main Business Overview
13.2.5 Novavax Latest Developments
13.3 Saiba Animal Health
13.3.1 Saiba Animal Health Company Information
13.3.2 Saiba Animal Health VLP Vaccines Product Portfolios and Specifications
13.3.3 Saiba Animal Health VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Saiba Animal Health Main Business Overview
13.3.5 Saiba Animal Health Latest Developments
13.4 VBI
13.4.1 VBI Company Information
13.4.2 VBI VLP Vaccines Product Portfolios and Specifications
13.4.3 VBI VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 VBI Main Business Overview
13.4.5 VBI Latest Developments
13.5 ARTES Biotechnology
13.5.1 ARTES Biotechnology Company Information
13.5.2 ARTES Biotechnology VLP Vaccines Product Portfolios and Specifications
13.5.3 ARTES Biotechnology VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 ARTES Biotechnology Main Business Overview
13.5.5 ARTES Biotechnology Latest Developments
13.6 VLP Therapeutics
13.6.1 VLP Therapeutics Company Information
13.6.2 VLP Therapeutics VLP Vaccines Product Portfolios and Specifications
13.6.3 VLP Therapeutics VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 VLP Therapeutics Main Business Overview
13.6.5 VLP Therapeutics Latest Developments
13.7 POSVAX
13.7.1 POSVAX Company Information
13.7.2 POSVAX VLP Vaccines Product Portfolios and Specifications
13.7.3 POSVAX VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 POSVAX Main Business Overview
13.7.5 POSVAX Latest Developments
13.8 Spybiotech
13.8.1 Spybiotech Company Information
13.8.2 Spybiotech VLP Vaccines Product Portfolios and Specifications
13.8.3 Spybiotech VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Spybiotech Main Business Overview
13.8.5 Spybiotech Latest Developments
13.9 Optipharm Co. Ltd
13.9.1 Optipharm Co. Ltd Company Information
13.9.2 Optipharm Co. Ltd VLP Vaccines Product Portfolios and Specifications
13.9.3 Optipharm Co. Ltd VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Optipharm Co. Ltd Main Business Overview
13.9.5 Optipharm Co. Ltd Latest Developments
13.10 H&Z Life Science
13.10.1 H&Z Life Science Company Information
13.10.2 H&Z Life Science VLP Vaccines Product Portfolios and Specifications
13.10.3 H&Z Life Science VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 H&Z Life Science Main Business Overview
13.10.5 H&Z Life Science Latest Developments
13.11 Gproan
13.11.1 Gproan Company Information
13.11.2 Gproan VLP Vaccines Product Portfolios and Specifications
13.11.3 Gproan VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Gproan Main Business Overview
13.11.5 Gproan Latest Developments
13.12 Merck
13.12.1 Merck Company Information
13.12.2 Merck VLP Vaccines Product Portfolios and Specifications
13.12.3 Merck VLP Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Merck Main Business Overview
13.12.5 Merck Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. VLP Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. VLP Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of HPV Vaccine
Table 4. Major Players of Covid-19 Vaccine
Table 5. Major Players of Hepatitis B Vaccine
Table 6. Major Players of Others
Table 7. Global VLP Vaccines Sales by Type (2018-2023) & (K Doses)
Table 8. Global VLP Vaccines Sales Market Share by Type (2018-2023)
Table 9. Global VLP Vaccines Revenue by Type (2018-2023) & ($ million)
Table 10. Global VLP Vaccines Revenue Market Share by Type (2018-2023)
Table 11. Global VLP Vaccines Sale Price by Type (2018-2023) & (US$/Dose)
Table 12. Global VLP Vaccines Sales by Application (2018-2023) & (K Doses)
Table 13. Global VLP Vaccines Sales Market Share by Application (2018-2023)
Table 14. Global VLP Vaccines Revenue by Application (2018-2023)
Table 15. Global VLP Vaccines Revenue Market Share by Application (2018-2023)
Table 16. Global VLP Vaccines Sale Price by Application (2018-2023) & (US$/Dose)
Table 17. Global VLP Vaccines Sales by Company (2018-2023) & (K Doses)
Table 18. Global VLP Vaccines Sales Market Share by Company (2018-2023)
Table 19. Global VLP Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 20. Global VLP Vaccines Revenue Market Share by Company (2018-2023)
Table 21. Global VLP Vaccines Sale Price by Company (2018-2023) & (US$/Dose)
Table 22. Key Manufacturers VLP Vaccines Producing Area Distribution and Sales Area
Table 23. Players VLP Vaccines Products Offered
Table 24. VLP Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global VLP Vaccines Sales by Geographic Region (2018-2023) & (K Doses)
Table 28. Global VLP Vaccines Sales Market Share Geographic Region (2018-2023)
Table 29. Global VLP Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global VLP Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global VLP Vaccines Sales by Country/Region (2018-2023) & (K Doses)
Table 32. Global VLP Vaccines Sales Market Share by Country/Region (2018-2023)
Table 33. Global VLP Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global VLP Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas VLP Vaccines Sales by Country (2018-2023) & (K Doses)
Table 36. Americas VLP Vaccines Sales Market Share by Country (2018-2023)
Table 37. Americas VLP Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas VLP Vaccines Revenue Market Share by Country (2018-2023)
Table 39. Americas VLP Vaccines Sales by Type (2018-2023) & (K Doses)
Table 40. Americas VLP Vaccines Sales by Application (2018-2023) & (K Doses)
Table 41. APAC VLP Vaccines Sales by Region (2018-2023) & (K Doses)
Table 42. APAC VLP Vaccines Sales Market Share by Region (2018-2023)
Table 43. APAC VLP Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC VLP Vaccines Revenue Market Share by Region (2018-2023)
Table 45. APAC VLP Vaccines Sales by Type (2018-2023) & (K Doses)
Table 46. APAC VLP Vaccines Sales by Application (2018-2023) & (K Doses)
Table 47. Europe VLP Vaccines Sales by Country (2018-2023) & (K Doses)
Table 48. Europe VLP Vaccines Sales Market Share by Country (2018-2023)
Table 49. Europe VLP Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe VLP Vaccines Revenue Market Share by Country (2018-2023)
Table 51. Europe VLP Vaccines Sales by Type (2018-2023) & (K Doses)
Table 52. Europe VLP Vaccines Sales by Application (2018-2023) & (K Doses)
Table 53. Middle East & Africa VLP Vaccines Sales by Country (2018-2023) & (K Doses)
Table 54. Middle East & Africa VLP Vaccines Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa VLP Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa VLP Vaccines Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa VLP Vaccines Sales by Type (2018-2023) & (K Doses)
Table 58. Middle East & Africa VLP Vaccines Sales by Application (2018-2023) & (K Doses)
Table 59. Key Market Drivers & Growth Opportunities of VLP Vaccines
Table 60. Key Market Challenges & Risks of VLP Vaccines
Table 61. Key Industry Trends of VLP Vaccines
Table 62. VLP Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. VLP Vaccines Distributors List
Table 65. VLP Vaccines Customer List
Table 66. Global VLP Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 67. Global VLP Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas VLP Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 69. Americas VLP Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC VLP Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 71. APAC VLP Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe VLP Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Europe VLP Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa VLP Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 75. Middle East & Africa VLP Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global VLP Vaccines Sales Forecast by Type (2024-2029) & (K Doses)
Table 77. Global VLP Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global VLP Vaccines Sales Forecast by Application (2024-2029) & (K Doses)
Table 79. Global VLP Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Medicago Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. Medicago VLP Vaccines Product Portfolios and Specifications
Table 82. Medicago VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 83. Medicago Main Business
Table 84. Medicago Latest Developments
Table 85. Novavax Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Novavax VLP Vaccines Product Portfolios and Specifications
Table 87. Novavax VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 88. Novavax Main Business
Table 89. Novavax Latest Developments
Table 90. Saiba Animal Health Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Saiba Animal Health VLP Vaccines Product Portfolios and Specifications
Table 92. Saiba Animal Health VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 93. Saiba Animal Health Main Business
Table 94. Saiba Animal Health Latest Developments
Table 95. VBI Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. VBI VLP Vaccines Product Portfolios and Specifications
Table 97. VBI VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 98. VBI Main Business
Table 99. VBI Latest Developments
Table 100. ARTES Biotechnology Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. ARTES Biotechnology VLP Vaccines Product Portfolios and Specifications
Table 102. ARTES Biotechnology VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 103. ARTES Biotechnology Main Business
Table 104. ARTES Biotechnology Latest Developments
Table 105. VLP Therapeutics Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. VLP Therapeutics VLP Vaccines Product Portfolios and Specifications
Table 107. VLP Therapeutics VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 108. VLP Therapeutics Main Business
Table 109. VLP Therapeutics Latest Developments
Table 110. POSVAX Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. POSVAX VLP Vaccines Product Portfolios and Specifications
Table 112. POSVAX VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 113. POSVAX Main Business
Table 114. POSVAX Latest Developments
Table 115. Spybiotech Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. Spybiotech VLP Vaccines Product Portfolios and Specifications
Table 117. Spybiotech VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 118. Spybiotech Main Business
Table 119. Spybiotech Latest Developments
Table 120. Optipharm Co. Ltd Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. Optipharm Co. Ltd VLP Vaccines Product Portfolios and Specifications
Table 122. Optipharm Co. Ltd VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 123. Optipharm Co. Ltd Main Business
Table 124. Optipharm Co. Ltd Latest Developments
Table 125. H&Z Life Science Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. H&Z Life Science VLP Vaccines Product Portfolios and Specifications
Table 127. H&Z Life Science VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 128. H&Z Life Science Main Business
Table 129. H&Z Life Science Latest Developments
Table 130. Gproan Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. Gproan VLP Vaccines Product Portfolios and Specifications
Table 132. Gproan VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 133. Gproan Main Business
Table 134. Gproan Latest Developments
Table 135. Merck Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. Merck VLP Vaccines Product Portfolios and Specifications
Table 137. Merck VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 138. Merck Main Business
Table 139. Merck Latest Developments
Table 1. VLP Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. VLP Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of HPV Vaccine
Table 4. Major Players of Covid-19 Vaccine
Table 5. Major Players of Hepatitis B Vaccine
Table 6. Major Players of Others
Table 7. Global VLP Vaccines Sales by Type (2018-2023) & (K Doses)
Table 8. Global VLP Vaccines Sales Market Share by Type (2018-2023)
Table 9. Global VLP Vaccines Revenue by Type (2018-2023) & ($ million)
Table 10. Global VLP Vaccines Revenue Market Share by Type (2018-2023)
Table 11. Global VLP Vaccines Sale Price by Type (2018-2023) & (US$/Dose)
Table 12. Global VLP Vaccines Sales by Application (2018-2023) & (K Doses)
Table 13. Global VLP Vaccines Sales Market Share by Application (2018-2023)
Table 14. Global VLP Vaccines Revenue by Application (2018-2023)
Table 15. Global VLP Vaccines Revenue Market Share by Application (2018-2023)
Table 16. Global VLP Vaccines Sale Price by Application (2018-2023) & (US$/Dose)
Table 17. Global VLP Vaccines Sales by Company (2018-2023) & (K Doses)
Table 18. Global VLP Vaccines Sales Market Share by Company (2018-2023)
Table 19. Global VLP Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 20. Global VLP Vaccines Revenue Market Share by Company (2018-2023)
Table 21. Global VLP Vaccines Sale Price by Company (2018-2023) & (US$/Dose)
Table 22. Key Manufacturers VLP Vaccines Producing Area Distribution and Sales Area
Table 23. Players VLP Vaccines Products Offered
Table 24. VLP Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global VLP Vaccines Sales by Geographic Region (2018-2023) & (K Doses)
Table 28. Global VLP Vaccines Sales Market Share Geographic Region (2018-2023)
Table 29. Global VLP Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global VLP Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global VLP Vaccines Sales by Country/Region (2018-2023) & (K Doses)
Table 32. Global VLP Vaccines Sales Market Share by Country/Region (2018-2023)
Table 33. Global VLP Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global VLP Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas VLP Vaccines Sales by Country (2018-2023) & (K Doses)
Table 36. Americas VLP Vaccines Sales Market Share by Country (2018-2023)
Table 37. Americas VLP Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas VLP Vaccines Revenue Market Share by Country (2018-2023)
Table 39. Americas VLP Vaccines Sales by Type (2018-2023) & (K Doses)
Table 40. Americas VLP Vaccines Sales by Application (2018-2023) & (K Doses)
Table 41. APAC VLP Vaccines Sales by Region (2018-2023) & (K Doses)
Table 42. APAC VLP Vaccines Sales Market Share by Region (2018-2023)
Table 43. APAC VLP Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC VLP Vaccines Revenue Market Share by Region (2018-2023)
Table 45. APAC VLP Vaccines Sales by Type (2018-2023) & (K Doses)
Table 46. APAC VLP Vaccines Sales by Application (2018-2023) & (K Doses)
Table 47. Europe VLP Vaccines Sales by Country (2018-2023) & (K Doses)
Table 48. Europe VLP Vaccines Sales Market Share by Country (2018-2023)
Table 49. Europe VLP Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe VLP Vaccines Revenue Market Share by Country (2018-2023)
Table 51. Europe VLP Vaccines Sales by Type (2018-2023) & (K Doses)
Table 52. Europe VLP Vaccines Sales by Application (2018-2023) & (K Doses)
Table 53. Middle East & Africa VLP Vaccines Sales by Country (2018-2023) & (K Doses)
Table 54. Middle East & Africa VLP Vaccines Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa VLP Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa VLP Vaccines Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa VLP Vaccines Sales by Type (2018-2023) & (K Doses)
Table 58. Middle East & Africa VLP Vaccines Sales by Application (2018-2023) & (K Doses)
Table 59. Key Market Drivers & Growth Opportunities of VLP Vaccines
Table 60. Key Market Challenges & Risks of VLP Vaccines
Table 61. Key Industry Trends of VLP Vaccines
Table 62. VLP Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. VLP Vaccines Distributors List
Table 65. VLP Vaccines Customer List
Table 66. Global VLP Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 67. Global VLP Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas VLP Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 69. Americas VLP Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC VLP Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 71. APAC VLP Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe VLP Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Europe VLP Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa VLP Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 75. Middle East & Africa VLP Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global VLP Vaccines Sales Forecast by Type (2024-2029) & (K Doses)
Table 77. Global VLP Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global VLP Vaccines Sales Forecast by Application (2024-2029) & (K Doses)
Table 79. Global VLP Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Medicago Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. Medicago VLP Vaccines Product Portfolios and Specifications
Table 82. Medicago VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 83. Medicago Main Business
Table 84. Medicago Latest Developments
Table 85. Novavax Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Novavax VLP Vaccines Product Portfolios and Specifications
Table 87. Novavax VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 88. Novavax Main Business
Table 89. Novavax Latest Developments
Table 90. Saiba Animal Health Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Saiba Animal Health VLP Vaccines Product Portfolios and Specifications
Table 92. Saiba Animal Health VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 93. Saiba Animal Health Main Business
Table 94. Saiba Animal Health Latest Developments
Table 95. VBI Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. VBI VLP Vaccines Product Portfolios and Specifications
Table 97. VBI VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 98. VBI Main Business
Table 99. VBI Latest Developments
Table 100. ARTES Biotechnology Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. ARTES Biotechnology VLP Vaccines Product Portfolios and Specifications
Table 102. ARTES Biotechnology VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 103. ARTES Biotechnology Main Business
Table 104. ARTES Biotechnology Latest Developments
Table 105. VLP Therapeutics Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. VLP Therapeutics VLP Vaccines Product Portfolios and Specifications
Table 107. VLP Therapeutics VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 108. VLP Therapeutics Main Business
Table 109. VLP Therapeutics Latest Developments
Table 110. POSVAX Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. POSVAX VLP Vaccines Product Portfolios and Specifications
Table 112. POSVAX VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 113. POSVAX Main Business
Table 114. POSVAX Latest Developments
Table 115. Spybiotech Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. Spybiotech VLP Vaccines Product Portfolios and Specifications
Table 117. Spybiotech VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 118. Spybiotech Main Business
Table 119. Spybiotech Latest Developments
Table 120. Optipharm Co. Ltd Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. Optipharm Co. Ltd VLP Vaccines Product Portfolios and Specifications
Table 122. Optipharm Co. Ltd VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 123. Optipharm Co. Ltd Main Business
Table 124. Optipharm Co. Ltd Latest Developments
Table 125. H&Z Life Science Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. H&Z Life Science VLP Vaccines Product Portfolios and Specifications
Table 127. H&Z Life Science VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 128. H&Z Life Science Main Business
Table 129. H&Z Life Science Latest Developments
Table 130. Gproan Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. Gproan VLP Vaccines Product Portfolios and Specifications
Table 132. Gproan VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 133. Gproan Main Business
Table 134. Gproan Latest Developments
Table 135. Merck Basic Information, VLP Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. Merck VLP Vaccines Product Portfolios and Specifications
Table 137. Merck VLP Vaccines Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 138. Merck Main Business
Table 139. Merck Latest Developments
LIST OF FIGURES
Figure 1. Picture of VLP Vaccines
Figure 2. VLP Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global VLP Vaccines Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global VLP Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. VLP Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of HPV Vaccine
Figure 10. Product Picture of Covid-19 Vaccine
Figure 11. Product Picture of Hepatitis B Vaccine
Figure 12. Product Picture of Others
Figure 13. Global VLP Vaccines Sales Market Share by Type in 2022
Figure 14. Global VLP Vaccines Revenue Market Share by Type (2018-2023)
Figure 15. VLP Vaccines Consumed in Government
Figure 16. Global VLP Vaccines Market: Government (2018-2023) & (K Doses)
Figure 17. VLP Vaccines Consumed in Medical Institution
Figure 18. Global VLP Vaccines Market: Medical Institution (2018-2023) & (K Doses)
Figure 19. VLP Vaccines Consumed in Others
Figure 20. Global VLP Vaccines Market: Others (2018-2023) & (K Doses)
Figure 21. Global VLP Vaccines Sales Market Share by Application (2022)
Figure 22. Global VLP Vaccines Revenue Market Share by Application in 2022
Figure 23. VLP Vaccines Sales Market by Company in 2022 (K Doses)
Figure 24. Global VLP Vaccines Sales Market Share by Company in 2022
Figure 25. VLP Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 26. Global VLP Vaccines Revenue Market Share by Company in 2022
Figure 27. Global VLP Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global VLP Vaccines Revenue Market Share by Geographic Region in 2022
Figure 29. Americas VLP Vaccines Sales 2018-2023 (K Doses)
Figure 30. Americas VLP Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. APAC VLP Vaccines Sales 2018-2023 (K Doses)
Figure 32. APAC VLP Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Europe VLP Vaccines Sales 2018-2023 (K Doses)
Figure 34. Europe VLP Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa VLP Vaccines Sales 2018-2023 (K Doses)
Figure 36. Middle East & Africa VLP Vaccines Revenue 2018-2023 ($ Millions)
Figure 37. Americas VLP Vaccines Sales Market Share by Country in 2022
Figure 38. Americas VLP Vaccines Revenue Market Share by Country in 2022
Figure 39. Americas VLP Vaccines Sales Market Share by Type (2018-2023)
Figure 40. Americas VLP Vaccines Sales Market Share by Application (2018-2023)
Figure 41. United States VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC VLP Vaccines Sales Market Share by Region in 2022
Figure 46. APAC VLP Vaccines Revenue Market Share by Regions in 2022
Figure 47. APAC VLP Vaccines Sales Market Share by Type (2018-2023)
Figure 48. APAC VLP Vaccines Sales Market Share by Application (2018-2023)
Figure 49. China VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. India VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe VLP Vaccines Sales Market Share by Country in 2022
Figure 57. Europe VLP Vaccines Revenue Market Share by Country in 2022
Figure 58. Europe VLP Vaccines Sales Market Share by Type (2018-2023)
Figure 59. Europe VLP Vaccines Sales Market Share by Application (2018-2023)
Figure 60. Germany VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. France VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa VLP Vaccines Sales Market Share by Country in 2022
Figure 66. Middle East & Africa VLP Vaccines Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa VLP Vaccines Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa VLP Vaccines Sales Market Share by Application (2018-2023)
Figure 69. Egypt VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of VLP Vaccines in 2022
Figure 75. Manufacturing Process Analysis of VLP Vaccines
Figure 76. Industry Chain Structure of VLP Vaccines
Figure 77. Channels of Distribution
Figure 78. Global VLP Vaccines Sales Market Forecast by Region (2024-2029)
Figure 79. Global VLP Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global VLP Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global VLP Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global VLP Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global VLP Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of VLP Vaccines
Figure 2. VLP Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global VLP Vaccines Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global VLP Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. VLP Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of HPV Vaccine
Figure 10. Product Picture of Covid-19 Vaccine
Figure 11. Product Picture of Hepatitis B Vaccine
Figure 12. Product Picture of Others
Figure 13. Global VLP Vaccines Sales Market Share by Type in 2022
Figure 14. Global VLP Vaccines Revenue Market Share by Type (2018-2023)
Figure 15. VLP Vaccines Consumed in Government
Figure 16. Global VLP Vaccines Market: Government (2018-2023) & (K Doses)
Figure 17. VLP Vaccines Consumed in Medical Institution
Figure 18. Global VLP Vaccines Market: Medical Institution (2018-2023) & (K Doses)
Figure 19. VLP Vaccines Consumed in Others
Figure 20. Global VLP Vaccines Market: Others (2018-2023) & (K Doses)
Figure 21. Global VLP Vaccines Sales Market Share by Application (2022)
Figure 22. Global VLP Vaccines Revenue Market Share by Application in 2022
Figure 23. VLP Vaccines Sales Market by Company in 2022 (K Doses)
Figure 24. Global VLP Vaccines Sales Market Share by Company in 2022
Figure 25. VLP Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 26. Global VLP Vaccines Revenue Market Share by Company in 2022
Figure 27. Global VLP Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global VLP Vaccines Revenue Market Share by Geographic Region in 2022
Figure 29. Americas VLP Vaccines Sales 2018-2023 (K Doses)
Figure 30. Americas VLP Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. APAC VLP Vaccines Sales 2018-2023 (K Doses)
Figure 32. APAC VLP Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Europe VLP Vaccines Sales 2018-2023 (K Doses)
Figure 34. Europe VLP Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa VLP Vaccines Sales 2018-2023 (K Doses)
Figure 36. Middle East & Africa VLP Vaccines Revenue 2018-2023 ($ Millions)
Figure 37. Americas VLP Vaccines Sales Market Share by Country in 2022
Figure 38. Americas VLP Vaccines Revenue Market Share by Country in 2022
Figure 39. Americas VLP Vaccines Sales Market Share by Type (2018-2023)
Figure 40. Americas VLP Vaccines Sales Market Share by Application (2018-2023)
Figure 41. United States VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC VLP Vaccines Sales Market Share by Region in 2022
Figure 46. APAC VLP Vaccines Revenue Market Share by Regions in 2022
Figure 47. APAC VLP Vaccines Sales Market Share by Type (2018-2023)
Figure 48. APAC VLP Vaccines Sales Market Share by Application (2018-2023)
Figure 49. China VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. India VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe VLP Vaccines Sales Market Share by Country in 2022
Figure 57. Europe VLP Vaccines Revenue Market Share by Country in 2022
Figure 58. Europe VLP Vaccines Sales Market Share by Type (2018-2023)
Figure 59. Europe VLP Vaccines Sales Market Share by Application (2018-2023)
Figure 60. Germany VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. France VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa VLP Vaccines Sales Market Share by Country in 2022
Figure 66. Middle East & Africa VLP Vaccines Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa VLP Vaccines Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa VLP Vaccines Sales Market Share by Application (2018-2023)
Figure 69. Egypt VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country VLP Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of VLP Vaccines in 2022
Figure 75. Manufacturing Process Analysis of VLP Vaccines
Figure 76. Industry Chain Structure of VLP Vaccines
Figure 77. Channels of Distribution
Figure 78. Global VLP Vaccines Sales Market Forecast by Region (2024-2029)
Figure 79. Global VLP Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global VLP Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global VLP Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global VLP Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global VLP Vaccines Revenue Market Share Forecast by Application (2024-2029)
